Home › Funds › Two Sigma Investments › RPRX
Two Sigma Investments position in RPRX
ROYALTY PHARMA PLC · Health Care
Latest position (Q2 2026)2.92M sh
Reported value held$163.73M
Portfolio Weight0.13%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 160.78K | $6.41M | New |
| Q1 2022 | 187.03K | $7.29M | Add |
| Q2 2022 | 470.95K | $19.80M | Add |
| Q3 2022 | 791.34K | $31.80M | Add |
| Q4 2022 | 440.11K | $17.39M | Reduce |
| Q1 2023 | 174.28K | $6.28M | Reduce |
| Q2 2023 | 1.13M | $34.79M | Add |
| Q3 2023 | 2.21M | $59.89M | Add |
| Q4 2023 | 2.11M | $59.31M | Reduce |
| Q1 2024 | 1.30M | $39.59M | Reduce |
| Q2 2024 | 2.06M | $54.26M | Add |
| Q3 2024 | 2.43M | $68.73M | Add |
| Q4 2024 | 2.42M | $61.74M | Hold |
| Q1 2025 | 1.61M | $50.21M | Reduce |
| Q2 2025 | 54.10K | $1.95M | Reduce |
| Q3 2025 | 1.18M | $41.78M | Add |
| Q4 2025 | 681.25K | $26.32M | Reduce |
| Q1 2026 | 2.25M | $108.01M | Add |
| Q2 2026 | 2.92M | $163.73M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RPRX
- Morgan Stanley 42.93M sh · $2.41B · Q2 2026
- BlackRock Inc 27.83M sh · $1.56B · Q2 2026
- Fidelity Management & Research (FMR) 24.51M sh · $1.37B · Q2 2026
- Baillie Gifford & Co 10.02M sh · $561.57M · Q2 2026
- Capital World Investors 9.52M sh · $533.64M · Q2 2026
- Geode Capital Management 8.06M sh · $450.58M · Q2 2026
- Vanguard Group 9.93M sh · $383.87M · Q4 2025
- Norges Bank Investment Management 5.34M sh · $299.19M · Q2 2026
- Northern Trust Corp 4.72M sh · $264.59M · Q2 2026
- AQR Capital Management 4.31M sh · $241.40M · Q2 2026
- Invesco Ltd 4.23M sh · $237.32M · Q2 2026
- Bank of America Corp 4.15M sh · $232.66M · Q2 2026